Cas no 202925-09-5 (Benzaldehyde,4-chloro-3-fluoro-, oxime)
Benzaldehyde,4-chloro-3-fluoro-, oxime Chemical and Physical Properties
Names and Identifiers
-
- Benzaldehyde,4-chloro-3-fluoro-, oxime
- 4-Chloro-3-fluorobenzaldoxiMe
- N-[(4-chloro-3-fluorophenyl)methylidene]hydroxylamine
- 4-Chloro-3-fluorobenzaldehyde oxime
- DTXSID40378578
- 202925-09-5
-
- Inchi: 1S/C7H5ClFNO/c8-6-2-1-5(4-10-11)3-7(6)9/h1-4,11H
- InChI Key: OMBFOEPKXLLRRV-UHFFFAOYSA-N
- SMILES: ClC1C=CC(C=NO)=CC=1F
Computed Properties
- Exact Mass: 173.00400
- Monoisotopic Mass: 173.0043696g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 153
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 1
- XLogP3: 2.4
- Topological Polar Surface Area: 32.6?2
Experimental Properties
- Density: 1.418
- Boiling Point: 325.6 °C at 760 mmHg
- Flash Point: 150.7 °C
- Refractive Index: 1.533
- PSA: 32.59000
- LogP: 2.28720
Benzaldehyde,4-chloro-3-fluoro-, oxime Security Information
- Hazard Statement: Irritant
-
Hazardous Material Identification:
Benzaldehyde,4-chloro-3-fluoro-, oxime Customs Data
- HS CODE:2928000090
- Customs Data:
China Customs Code:
2928000090Overview:
2928000090 Other hydrazine(Hydrazine)And chlorhexidine(hydroxylamine)Organic derivatives of.Regulatory conditions:nothing.VAT:17.0%.Tax refund rate:9.0%.MFN tariff:6.5%.general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2928000090 other organic derivatives of hydrazine or of hydroxylamine VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%
Benzaldehyde,4-chloro-3-fluoro-, oxime Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB134966-5g |
4-Chloro-3-fluorobenzaldoxime; . |
202925-09-5 | 5g |
€217.60 | 2025-04-20 | ||
| abcr | AB134966-10g |
4-Chloro-3-fluorobenzaldoxime; . |
202925-09-5 | 10g |
€331.50 | 2025-04-20 | ||
| abcr | AB134966-25g |
4-Chloro-3-fluorobenzaldoxime; . |
202925-09-5 | 25g |
€601.80 | 2025-04-20 | ||
| abcr | AB134966-100g |
4-Chloro-3-fluorobenzaldoxime; . |
202925-09-5 | 100g |
€1785.10 | 2025-04-20 |
Benzaldehyde,4-chloro-3-fluoro-, oxime Related Literature
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
Additional information on Benzaldehyde,4-chloro-3-fluoro-, oxime
Benzaldehyde,4-chloro-3-fluoro-, oxime and Its Significance in Modern Chemical Research
Benzaldehyde,4-chloro-3-fluoro-, oxime (CAS No. 202925-09-5) is a fluorinated aromatic aldehyde derivative that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, characterized by its unique structural motifs, exhibits promising properties that make it a valuable scaffold for the development of novel bioactive molecules. The presence of both chloro and fluoro substituents in its structure enhances its reactivity and selectivity, making it a versatile intermediate in synthetic chemistry.
The< strong>oxime functional group in this compound plays a crucial role in its biological activity. Oximes are well-known for their ability to chelate metal ions, which has been exploited in various therapeutic applications. In recent years, there has been a surge in research focused on the development of metal-binding agents for therapeutic purposes, particularly in the treatment of metalloproteinase-related diseases and metal intoxication. The oxime moiety in Benzaldehyde,4-chloro-3-fluoro-, oxime provides a unique opportunity to explore such applications due to its strong chelating properties and tunable electronic characteristics.
One of the most compelling aspects of Benzaldehyde,4-chloro-3-fluoro-, oxime is its potential as a building block for the synthesis of more complex molecules. The chloro and fluoro substituents introduce regions of electrophilic and nucleophilic reactivity, respectively, which can be exploited to construct diverse molecular architectures. This property has been particularly useful in the development of kinase inhibitors, which are critical targets in oncology research. Recent studies have demonstrated that fluorinated aldehydes can serve as effective scaffolds for designing potent kinase inhibitors by modulating binding affinity and selectivity.
In the realm of drug discovery, the< strong>fluorine atom is increasingly recognized for its ability to enhance metabolic stability and binding affinity. The introduction of fluorine into aromatic rings can lead to significant improvements in pharmacokinetic properties, making fluorinated compounds highly desirable in medicinal chemistry. The< strong>4-chloro-3-fluoro-substituted benzaldehyde oxime structure exemplifies this trend, as it combines the benefits of both fluorine and chlorine substituents to create a highly versatile synthetic intermediate.
The< strong>oxime group also contributes to the unique electronic properties of this compound. Oximes can exhibit both π-conjugation and metal coordination capabilities, which can be leveraged to design molecules with specific biological activities. For instance, studies have shown that oxime-based compounds can interact with various biological targets, including enzymes and receptors, leading to potential therapeutic effects. The combination of these features makes Benzaldehyde,4-chloro-3-fluoro-, oxime an attractive candidate for further exploration in drug discovery.
The synthesis of< strong>Benzaldehyde,4-chloro-3-fluoro-, oxime involves multi-step organic transformations that highlight its synthetic utility. The process typically begins with the functionalization of a benzaldehyde precursor, followed by introducing the chloro and fluoro substituents at specific positions on the aromatic ring. The final step involves the formation of the oxime group through condensation with hydroxylamine or its derivatives. This synthetic route underscores the compound's importance as a key intermediate in organic synthesis.
In recent years, there has been growing interest in the use of computational methods to study the properties of< strong>Benzaldehyde,4-chloro-3-fluoro-, oxime. Molecular modeling techniques have been employed to predict its binding interactions with biological targets, providing valuable insights into its potential therapeutic applications. These computational studies have helped researchers optimize its structure for improved bioactivity and selectivity. Such advancements highlight the importance of interdisciplinary approaches in modern chemical research.
The< strong>CAS No. 202925-09-5 designation ensures that researchers have access to reliable information about this compound's properties and applications. This standardized identification system is crucial for ensuring consistency and accuracy in scientific literature and patents. As more studies are published on Benzaldehyde,4-chloro-3-fluoro-, oxime, it is expected that its role in pharmaceutical research will continue to expand.
In conclusion,< strong>Benzaldehyde,4-chloro-3-fluoro-, oxime represents a significant advancement in chemical research due to its unique structural features and promising biological activities. Its combination of chloro, fluoro substituents, and an oxime functional group makes it a valuable scaffold for developing novel bioactive molecules. As research progresses, it is likely that this compound will find even broader applications in pharmaceuticals and other industries.
202925-09-5 (Benzaldehyde,4-chloro-3-fluoro-, oxime) Related Products
- 1629614-97-6((E)-4-chloro-2-fluorobenzaldehyde oxime)
- 159693-00-2(4-Chloro-2-fluorobenzaldoxime)
- 430534-88-6(BENZENECARBOXIMIDOYL CHLORIDE, 3-CHLORO-4-FLUORO-N-HYDROXY-)
- 2055296-76-7((NE)-N-[(4-chloro-2,3-difluorophenyl)methylidene]hydroxylamine)
- 890934-28-8(3-Chloro-2-fluorobenzaldehyde oxime)
- 658-09-3(Ethanone, 1-(3-chloro-4-fluorophenyl)-, oxime)
- 212631-82-8(5-Chloro-2-fluorobenzaldehyde oxime)
- 890934-19-7(2-Chloro-4-fluorobenzaldoxime)
- 430534-91-1(Benzenecarboximidoyl chloride, 4-chloro-3-fluoro-N-hydroxy-)
- 253308-63-3(3-Chloro-4-fluorobenzaldehyde Oxime)